tradingkey.logo

Anika Therapeutics Inc

ANIK
View Detailed Chart
9.570USD
0.000
Market hours ETQuotes delayed by 15 min
138.01MMarket Cap
LossP/E TTM

Anika Therapeutics Inc

9.570
0.000
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

+0.10%

1 Month

-3.14%

6 Months

-9.63%

Year to Date

-41.86%

1 Year

-41.32%

View Detailed Chart

Key Insights

Anika Therapeutics Inc's fundamentals are relatively very healthy, and its growth potential is good.Its valuation is considered fairly valued, ranking 48/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 16.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Anika Therapeutics Inc's Score

Industry at a Glance

Industry Ranking
48 / 208
Overall Ranking
131 / 4582
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 2 analysts
Strong Buy
Current Rating
16.000
Target Price
+66.15%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Anika Therapeutics Inc Highlights

StrengthsRisks
Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 119.91M.
Fairly Valued
The company’s latest PE is -4.21, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 12.37M shares, decreasing 0.01% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 780.66K shares of this stock.

Anika Therapeutics Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Anika Therapeutics Inc Info

Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.
Ticker SymbolANIK
CompanyAnika Therapeutics Inc
CEOBlanchard (Cheryl Renee)
Websitehttps://anika.com/

FAQs

What is the current price of Anika Therapeutics Inc (ANIK)?

The current price of Anika Therapeutics Inc (ANIK) is 9.570.

What is the symbol of Anika Therapeutics Inc?

The ticker symbol of Anika Therapeutics Inc is ANIK.

What is the 52-week high of Anika Therapeutics Inc?

The 52-week high of Anika Therapeutics Inc is 18.370.

What is the 52-week low of Anika Therapeutics Inc?

The 52-week low of Anika Therapeutics Inc is 7.870.

What is the market capitalization of Anika Therapeutics Inc?

The market capitalization of Anika Therapeutics Inc is 138.01M.

What is the net income of Anika Therapeutics Inc?

The net income of Anika Therapeutics Inc is -56.38M.

Is Anika Therapeutics Inc (ANIK) currently rated as Buy, Hold, or Sell?

According to analysts, Anika Therapeutics Inc (ANIK) has an overall rating of --, with a price target of 16.000.

What is the Earnings Per Share (EPS TTM) of Anika Therapeutics Inc (ANIK)?

The Earnings Per Share (EPS TTM) of Anika Therapeutics Inc (ANIK) is -2.271.
KeyAI